| X | ||||||||||
- Definition Weighted Average Exercise Price Per Warrant outstanding and exercisable, balance. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price nonoption exercised. No definition available.
|
| X | ||||||||||
- Definition Share based arrangements by share based payment award non options forfeited in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price Per Warrant, issued. No definition available.
|
| X | ||||||||||
- Definition Remaining Contract Term (years) Warrants outstanding and exercisable. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|